Insider · CIK 0001556914

Marek David C

Reports to the SEC for 3 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001556914

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-03-10	Myovant Sciences Ltd.D Disposition to Issuer	Director, Principal Executive Officer	DDisposition to Issuer	−95.7K sh	—	—	321,924
2023-03-10	Myovant Sciences Ltd.D Disposition to Issuer	Director, Principal Executive Officer	DDisposition to Issuer	−322K sh	—	—	0
2023-03-10	Myovant Sciences Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Director, Principal Executive Officer	DDisposition to Issuer	−306K sh	—	—	0
2023-03-10	Myovant Sciences Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Director, Principal Executive Officer	DDisposition to Issuer	−208K sh	—	—	0
2023-03-10	Myovant Sciences Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Director, Principal Executive Officer	DDisposition to Issuer	−205K sh	—	—	0
2023-03-10	Myovant Sciences Ltd.Performance Stock UnitD Disposition to Issuer	Director, Principal Executive Officer	DDisposition to Issuer	−135K sh	—	—	0
2023-01-18	Myovant Sciences Ltd.S Sale	Director, Principal Executive Officer	SSale	−8,037 sh	$26.89	−$216K	417,599
2022-10-18	Myovant Sciences Ltd.S Sale	Director, Principal Executive Officer	SSale	−11.2K sh	$25.20	−$281K	425,636
2022-07-18	Myovant Sciences Ltd.S Sale	Director, Principal Executive Officer	SSale	−11.2K sh	$12.87	−$144K	436,792
2022-04-19	Myovant Sciences Ltd.S Sale	Director, Principal Executive Officer	SSale	−24.6K sh	$10.45	−$257K	447,956
2022-04-15	Myovant Sciences Ltd.A Award	Director, Principal Executive Officer	AAward	+135K sh	—	—	472,550
2022-04-15	Myovant Sciences Ltd.Stock Option (Right to Buy)A Award	Director, Principal Executive Officer	AAward	+205K sh	—	—	204,808
2022-01-19	Myovant Sciences Ltd.S Sale	Director, Principal Executive Officer	SSale	−19.9K sh	$14.68	−$292K	337,983
2021-04-15	Myovant Sciences Ltd.A Award	Director, Principal Executive Officer	AAward	+135K sh	—	—	357,865
2021-04-15	Myovant Sciences Ltd.Stock Option (Right to Buy)A Award	Director, Principal Executive Officer	AAward	+208K sh	—	—	208,218
2021-01-15	Myovant Sciences Ltd.A Award	Director, Principal Executive Officer	AAward	+223K sh	—	—	223,076
2021-01-15	Myovant Sciences Ltd.Stock Option (Right to Buy)A Award	Director, Principal Executive Officer	AAward	+306K sh	—	—	306,427
2020-03-17	AXSMAxsome Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+54K sh	—	—	53,984
2020-03-17	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Commercial Officer	AAward	+16.5K sh	—	—	16,533
2019-10-10	AXSMAxsome Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+25.8K sh	—	—	25,813
2019-09-04	AXSMAxsome Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+125K sh	—	—	125,000
2013-09-04	WebMD Health Corp.F Tax Payment	Executive Vice President	FTax Payment	−925 sh	$32.82	−$30.4K	9,075
2012-09-04	WebMD Health Corp.A Award	Executive Vice President	AAward	+10K sh	—	—	10,000
2012-09-04	WebMD Health Corp.Stock Option (Right to Buy)A Award	Executive Vice President	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Mar 104
Marek David C0001209191-23-017720
SEC(opens sec.gov)
Jan 204
Marek David C0001209191-23-004282
SEC(opens sec.gov)
Oct 204
Marek David C0001209191-22-054196
SEC(opens sec.gov)
Jul 204
Marek David C0001209191-22-042688
SEC(opens sec.gov)
Apr 214
Marek David C0001209191-22-025170
SEC(opens sec.gov)
Apr 194
Marek David C0001209191-22-024784
SEC(opens sec.gov)
Jan 214
Marek David C0001209191-22-004396
SEC(opens sec.gov)
Apr 194
Marek David C0001209191-21-027277
SEC(opens sec.gov)
Jan 204
Marek David C0001209191-21-004330
SEC(opens sec.gov)
Mar 194
Marek David C0001179110-20-004009
SEC(opens sec.gov)
Oct 154
Marek David C0001179110-19-011011
SEC(opens sec.gov)

Companies

Address

C/O WEBMD HEALTH CORP. 111 EIGHTH AVENUE

NEW YORK, NY, 10011